US Map / Missouri
State MO

Clinical Trials in Missouri

Recruiting clinical trials with at least one study location in Missouri. Data updated daily from ClinicalTrials.gov.

Total Trials
272
Recruiting Now
272
← Back to US Map
Top Conditions in Missouri
Non-small Cell Lung Cancer (6)Advanced Solid Tumor (5)Metastatic Breast Cancer (5)Cardiovascular Diseases (5)Heart Failure (5)Breast Cancer (5)Head and Neck Squamous Cell Carcinoma (4)Multiple Sclerosis (4)Major Depressive Disorder (3)Atopic Dermatitis (3)Stage IVB Prostate Cancer AJCC v8 (3)Pancreatic Ductal Adenocarcinoma (3)
NCT05987241 Phase 2, Phase 3
Recruiting
Testing the Role of DNA Released From Tumor Cells Into the Blood in Guiding the ...
Condition
Muscle Invasive Bladder Urothelial Carcinoma
Enrollment
992 pts
Location
United States, Canada
Sponsor
National Cancer Institute (NCI
View Trial →
NCT01255748 N/A
Recruiting
Registry Study for Radiation Therapy Outcomes
Condition
Neoplasms
Enrollment
40,000 pts
Location
United States
Sponsor
Proton Collaborative Group
View Trial →
NCT06218914 Phase 1
Recruiting
Phase 1 Study to Investigate TCRTs KRAS Mutation in Unresectable, Advanced, and/...
Condition
Non-small Cell Lung Cancer
Enrollment
108 pts
Location
United States
Sponsor
AstraZeneca
View Trial →
NCT06588647 N/A
Recruiting
Improving Participation After Stroke Self-Management-Rehabilitation
Condition
Stroke
Enrollment
100 pts
Location
United States
Sponsor
University of Missouri-Columbi
View Trial →
NCT06636838 N/A
Recruiting
Language Matters: Exploring the Impact of Language Concordance on Fertility Trea...
Condition
Infertility
Enrollment
70 pts
Location
United States
Sponsor
Washington University School o
View Trial →
NCT07298447 Phase 3
Recruiting
Donidalorsen Treatment in Children With Hereditary Angioedema
Condition
Hereditary Angioedema (HAE)
Enrollment
20 pts
Location
United States
Sponsor
Ionis Pharmaceuticals, Inc.
View Trial →
NCT04262206 Phase 4
Recruiting
Pragmatic Evaluation of Events And Benefits of Lipid-lowering in Older Adults
Condition
Cognitive Impairment, Mild
Enrollment
20,000 pts
Location
United States, Puerto Rico
Sponsor
Duke University
View Trial →
NCT05277558 N/A
Recruiting
Brain Health in Youth With Normal Weight, Overweight and Obesity at Risk for Typ...
Condition
Type2 Diabetes
Enrollment
117 pts
Location
United States
Sponsor
Washington University School o
View Trial →
NCT06745063 Phase 2
Recruiting
Arterial Destiffening Effects of SGLT2 Inhibition in Veterans With Obesity
Condition
Obesity
Enrollment
50 pts
Location
United States
Sponsor
VA Office of Research and Deve
View Trial →
NCT04640584 N/A
Recruiting
C-Brace Prospective Registry
Condition
Pareses
Enrollment
250 pts
Location
United States, Australia, Germany
Sponsor
Otto Bock Healthcare Products
View Trial →
NCT06388733 Phase 3
Recruiting
A Study Comparing Niraparib With Temozolomide in Adult Participants With Newly-d...
Condition
Glioblastoma
Enrollment
450 pts
Location
United States, Australia, Canada
Sponsor
Ivy Brain Tumor Center
View Trial →
NCT04868604 Phase 1, Phase 2
Recruiting
64Cu-SAR-bisPSMA and 67Cu-SAR-bisPSMA for Identification and Treatment of PSMA-e...
Condition
Prostatic Neoplasms, Castration-Resistant
Enrollment
54 pts
Location
United States
Sponsor
Clarity Pharmaceuticals Ltd
View Trial →
NCT06712316 Phase 2, Phase 3
Recruiting
Safety, Efficacy, and Pharmacokinetics of BNT327 in Combination With Chemotherap...
Condition
Non-small Cell Lung Cancer
Enrollment
1,260 pts
Location
United States, Australia, Belgium
Sponsor
BioNTech SE
View Trial →
NCT07488793 N/A
Recruiting
Remote Ischemic Conditioning for PwSCI
Condition
Spinal Cord Injuries
Enrollment
24 pts
Location
United States
Sponsor
Washington University School o
View Trial →
NCT05521984 Phase 1
Recruiting
Targeting Pediatric Brain Tumors and Relapsed/Refractory Solid Tumors With Sodiu...
Condition
Pediatric Brain Tumor
Enrollment
20 pts
Location
United States
Sponsor
Washington University School o
View Trial →
NCT04336644 N/A
Recruiting
Continuous Versus Intermittent cARdiac Electrical moNitorinG
Condition
Torsades de Pointe Caused by Drug
Enrollment
60 pts
Location
United States
Sponsor
Washington University School o
View Trial →
NCT01351545 N/A
Recruiting
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord...
Condition
Hematologic Malignancies
Enrollment
99,999 pts
Location
United States
Sponsor
Center for International Blood
View Trial →
NCT07477639 Phase 1, Phase 2
Recruiting
Treatment of Participants With Primary or Secondary Progressive Multiple Scleros...
Condition
Primary Progressive Multiple Sclerosis
Enrollment
39 pts
Location
United States
Sponsor
Tr1X, Inc.
View Trial →
NCT07024875 N/A
Recruiting
Neuroimaging of Parkinson's
Condition
Parkinsons Disease (PD)
Enrollment
120 pts
Location
United States
Sponsor
Washington University School o
View Trial →
NCT07116967 Phase 3
Recruiting
Long-Term Safety Study of Deucravacitinib Versus Ustekinumab in Participants Wit...
Condition
Plaque Psoriasis
Enrollment
3,040 pts
Location
United States, Argentina, Australia
Sponsor
Bristol-Myers Squibb
View Trial →
NCT06632457 Phase 3
Recruiting
LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a L...
Condition
Metabolic Dysfunction Associated Steatohepatitis
Enrollment
1,590 pts
Location
United States, Argentina, Australia
Sponsor
Boehringer Ingelheim
View Trial →
NCT06568367 Phase 3
Recruiting
Studying Solriamfetol Modulation of TAAR-1, Dopamine, and Norepinephrine in Shif...
Condition
Excessive Sleepiness
Enrollment
520 pts
Location
United States, Canada
Sponsor
Axsome Therapeutics, Inc.
View Trial →
NCT05965245 N/A
Recruiting
Suubi-Mhealth: A Mobile Health Intervention to Address Depression Among Youth
Condition
Depression
Enrollment
278 pts
Location
United States, Uganda
Sponsor
Washington University School o
View Trial →
NCT07136012 Phase 3
Recruiting
OCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And LipoproteiN(a)...
Condition
Cardiovascular Disease
Enrollment
11,000 pts
Location
United States, Australia, Canada
Sponsor
Amgen
View Trial →
NCT04047628 Phase 3
Recruiting
Best Available Therapy Versus Autologous Hematopoietic Stem Cell Transplant for ...
Condition
Relapsing Multiple Sclerosis
Enrollment
156 pts
Location
United States
Sponsor
National Institute of Allergy
View Trial →
Page 9 of 11 — 272 trials total
← Prev Next →